GE HealthCare Technologies Other Operating Income or Expenses 2020-2025 | GEHC
GE HealthCare Technologies annual/quarterly other operating income or expenses history and growth rate from 2020 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- GE HealthCare Technologies other operating income or expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
- GE HealthCare Technologies other operating income or expenses for the twelve months ending March 31, 2025 were $0M, a 0% increase year-over-year.
- GE HealthCare Technologies annual other operating income or expenses for 2024 were $0B, a 0% decline from 2023.
- GE HealthCare Technologies annual other operating income or expenses for 2023 were $0B, a 0% decline from 2022.
- GE HealthCare Technologies annual other operating income or expenses for 2022 were $0B, a 0% decline from 2021.
| GE HealthCare Technologies Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| GE HealthCare Technologies Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $31.796B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.788B | 27.51 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $144.385B | 30.19 |
| EssilorLuxottica (ESLOY) | France | $135.514B | 0.00 |
| Medtronic (MDT) | Ireland | $103.771B | 14.71 |
| Haleon (HLN) | United Kingdom | $49.845B | 28.36 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.977B | 0.00 |
| ResMed (RMD) | United States | $35.996B | 27.04 |
| Agilent Technologies (A) | United States | $31.270B | 20.66 |
| Terumo (TRUMY) | Japan | $27.864B | 36.19 |
| Insulet (PODD) | United States | $22.590B | 88.67 |
| Koninklijke Philips (PHG) | Netherlands | $21.684B | 15.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.137B | 11.65 |
| Baxter (BAX) | United States | $15.534B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.438B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.181B | 21.51 |
| Lantheus Holdings (LNTH) | United States | $5.172B | 13.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.201B | 18.77 |
| Perrigo (PRGO) | Ireland | $3.629B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Haemonetics (HAE) | United States | $3.178B | 14.48 |
| Envista Holdings (NVST) | United States | $2.859B | 23.76 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.788B | 39.96 |
| AtriCure (ATRC) | United States | $1.624B | 0.00 |
| Neogen (NEOG) | United States | $1.343B | 17.19 |
| Acuren (TIC) | United States | $1.288B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.206B | 12.25 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| Kestra Medical Technologies (KMTS) | United States | $1.145B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.933B | 11.93 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Evolus (EOLS) | United States | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.584B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.558B | 0.00 |
| Owens & Minor (OMI) | United States | $0.532B | 4.41 |
| Valneva SE (VALN) | France | $0.529B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.496B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.355B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 54.90 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.258B | 21.73 |
| Sanuwave Health (SNWV) | United States | $0.247B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.233B | 10.57 |
| Biote (BTMD) | United States | $0.205B | 5.77 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| OraSure Technologies (OSUR) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Agape ATP (ATPC) | $0.112B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.17 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |